Login / Signup

Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial.

Nicola C EdwardsAnna M PriceSamir MehtaThomas F HiemstraAmreen KaurPeter J GreasleyDavid J WebbNeeraj DhaunIain M MacIntyreTariq FarrahVanessa MelvilleAnna S HerreyGemma SlinnRebekah WaleNatalie IvesDavid C WheelerIan WilkinsonRichard P SteedsCharles J FerroJonathan N Townend
Published in: Clinical journal of the American Society of Nephrology : CJASN (2021)
Spironolactone was not superior to chlorthalidone in reducing left ventricular mass, BP, or arterial stiffness in nondiabetic CKD.
Keyphrases